UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients Journal article
Guan, Shaoxing, Shi, Wei, Zhao, Zerui, Wang, Fei, Jiang, Fulin, Zhang, Caibin, Jin, Zhongming, Guan, Yanping, Liu, Dihan, Zhong, Guoping, Huang, Min, Long, Hao, Wang, Xueding. Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients[J]. Bioanalysis, 2019, 11(22), 2049-2060.
Authors:  Guan, Shaoxing;  Shi, Wei;  Zhao, Zerui;  Wang, Fei;  Jiang, Fulin; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:1.9/2.1 | Submit date:2022/05/23
Active Metabolites  Apatinib  Therapeutic Drug Monitoring  Uplc-ms/ms  
Quantification of permanent positively charged compounds in plasma using one-step dilution to reduce matrix effect in MS Journal article
Zhou W., Wu X., Li J., Hu X., Tam K.Y.. Quantification of permanent positively charged compounds in plasma using one-step dilution to reduce matrix effect in MS[J]. Bioanalysis, 2016, 8(6), 497-509.
Authors:  Zhou W.;  Wu X.;  Li J.;  Hu X.;  Tam K.Y.
Favorite | TC[WOS]:8 TC[Scopus]:8 | Submit date:2018/12/18
Charged Surface Hybrid Chromatography  Matrix Effect  One-step Protein Precipitation Dilution Technique  Permanent Positively Charged Compounds  Pk  Tail Vessel Microsampling  
Quantification of permanent positivelycharged compounds in plasma usingone-step dilution to reduce matrix effect in MS Journal article
Zhou, W., Wu, X., LI, J., Hu, X., Tam, K. Y.. Quantification of permanent positivelycharged compounds in plasma usingone-step dilution to reduce matrix effect in MS[J]. Bioanalysis, 2016, 497-509.
Authors:  Zhou, W.;  Wu, X.;  LI, J.;  Hu, X.;  Tam, K. Y.
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:1.9/2.1 | Submit date:2022/07/28
Charged Surface Hybrid Chromatography  Matrix Effect  One-step Protein Precipitation Dilution Technique  Permanent Positively Charged Compounds  Pk  Tail Vesselmicrosampling